China Ending Years-Long Crackdown Restores Optimism as Tech Giants Report
China wrapping up its crackdown on tech firms and switching to supporting the industry sets the tone as
2023-08-14 11:22
China Looks to Attract Foreign Investment as Its Economy Struggles
China’s State Council released a plan to further attract foreign investment and improve the business environment, including tax
2023-08-13 20:20
US Supreme Court Halts Purdue’s $6 Billion Opioid Pact, Will Hear Appeal
The US Supreme Court agreed to consider scuttling Purdue Pharma LP’s $6 billion opioid settlement, taking up a
2023-08-11 04:49
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
2023-08-10 14:58
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
2023-08-09 01:52
Bayer’s New CEO Says Nothing Off Table in Strategic Review
Bayer AG Chief Executive Officer Bill Anderson said nothing is off the table as he reviews the company’s
2023-08-08 21:58
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
2023-08-08 18:49
Bayer Lowers Revenue Forecasts for Crops and Drugs Units
Bayer AG reduced its sales forecasts for its crop science and pharma divisions this year, accounting for the
2023-08-08 14:26
Biotech Firm Vistagen Surges 1,370% on Social Anxiety Spray Trial Success
A beaten down micro-cap biotech company, Vistagen Therapeutics Inc., notched its best day ever, surging by as many
2023-08-08 04:15
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
2023-08-07 20:23
Rakuten’s Mikitani Spends a Fifth of His Time on Biotech Startup
Hiroshi Mikitani, whose Rakuten Group Inc. is losing billions of dollars to break into Japan’s wireless market, said
2023-08-07 05:26
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
2023-08-05 10:29